Total Company Value: Creative Medical Technology Holdings (CELZ)

This price chart for Creative Medical Technology (CELZ) illustrates the business valuation, which currently stands at -4.13. Creative Medical Technology is implementing proprietary cellular developments for joint and reproductive system therapies. Growth in value is driven by patents, interest from pharmaceutical behemoths, and successes in diabetes treatment. The operating model relies on external laboratory testing while maintaining full internal control over technologies.

Enterprise value is calculated as the sum of market capitalization and net debt, which allows for an assessment of the actual costs of a full business buyout inclusive of all liabilities. For Creative Medical Technology (CELZ), this total value metric including debt is critical, as the costs of expensive cell technology certification and regulatory risks directly impact the capital structure and the final valuation of the asset.